E. Terry Mamounas

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)

Jame Abraham, Matthew P Goetz, H. Rugo, 2018, Breast Cancer Research and Treatment.

Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG)

F. Holmes, J. Abraham, M. Pegram, 2018, Breast Cancer Research and Treatment.